Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review Clara MarquinaJedidiah I MortonZanfina Ademi Systematic Review Open access 24 January 2024 Pages: 373 - 392
The Validity of the EuroQol Health and Wellbeing Short Version (EQ-HWB-S) Instrument in Parents of Children With and Without Health Conditions Cate BaileyKim DalzielIn collaboration with the Quality of Life in Kids: Key evidence to strengthen decisions in Australia (QUOKKA) Project team Original Research Article Open access 18 January 2024 Pages: 163 - 179
Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds Alexander van HeusdenOliver Rivero-Ariasin collaboration with the Quality Of Life in Kids: Key Evidence to Strengthen Decisions in Australia (QUOKKA) Project Team Original Research Article Open access 18 January 2024 Pages: 129 - 145
Making Decision Models Fit for Purpose: The Importance of Ensuring Stakeholder Involvement Stephanie Harvard Editorial 18 January 2024 Pages: 249 - 252
The RETRIEVE Checklist for Studies Reporting the Elicitation of Stated Preferences for Child Health-Related Quality of Life Cate BaileyMartin HowellNancy Devlin Original Research Article Open access 13 January 2024 Pages: 435 - 446
Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy Zakile A. MfumbilwaMartijn J. H. G. SimonsVeerle M. H. Coupé Original Research Article Open access 09 January 2024 Pages: 419 - 434
Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia Dong-Won KangLi WangChan Shen Original Research Article 06 January 2024 Pages: 409 - 418
A Guide to an Iterative Approach to Model-Based Decision Making in Health and Medicine: An Iterative Decision-Making Framework Natalia KunstEmily A. BurgerEline Aas Practical Application 29 December 2023 Pages: 363 - 371
Palliative Care Costs in Different Ambulatory-Based Settings: A Systematic Review Ana Helena Perea-BelloMarta Trapero-BertranChristian Dürsteler Systematic Review Open access 27 December 2023 Pages: 301 - 318
An Exploratory Analysis of the Cost-Effectiveness of a Multi-cancer Early Detection Blood Test Compared with Standard of Care Screening in Ontario, Canada Diedron LewisWilliam W. L. WongSusan Horton Original Research Article 27 December 2023 Pages: 393 - 407
A Research Framework to Improve Health Disparity Evidence Gaps in Value Assessments T. Joseph Mattingly II Current Opinion 12 December 2023 Pages: 253 - 259
A Framework for the Fair Pricing of Medicines Mike Paulden Leading Article Open access 08 December 2023 Pages: 145 - 164
Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task Force Edward HenryHareth Al-JanabiEve Wittenberg Original Research Article Open access 02 December 2023 Pages: 343 - 362
Estimating the Treatment and Prophylactic Economic Value of New Antimicrobials in Managing Antibiotic Resistance and Serious Infections for Common Pathogens in the USA: A Population Modelling Study Jason GordonMaria GheorgheAmer Al-Taie Original Research Article Open access 24 November 2023 Pages: 329 - 341
Surrogacy and the Valuation of ATMPs: Taking Our Place in the Evidence Generation/Assessment Continuum Daniel GladwellOriana CianiStephen Palmer Current Opinion 22 November 2023 Pages: 137 - 144
Using Real-World Data to Inform Value-Based Contracts for Cell and Gene Therapies in Medicaid Antal ZemplenyiJim LeonardR. Brett McQueen Original Research Article Open access 21 November 2023 Pages: 319 - 328
Considerations for the Cure Assumption in an NICE Single Technology Appraisal of Nivolumab with Chemotherapy for Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer: Evidence Assessment Group Perspective Giovany Orozco-LealEugenie Evelynne JohnsonStephen Rice Commentary 20 November 2023 Pages: 133 - 136
Evaluating the Quantity and Quality of Health Economic Literature in Blinding Childhood Disorders: A Systematic Literature Review Lucinda J. TeohSalomey KellettJugnoo S. Rahi Systematic Review 16 November 2023 Pages: 275 - 299
Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study Renee JonesRachel O’Loughlinon behalf of the Quality of Life in Kids: Key Evidence to Strengthen Decisions in Australia (QUOKKA) Project Team Original Research Article Open access 13 November 2023 Pages: 39 - 55
Estimating Costs Associated with Disease Model States Using Generalized Linear Models: A Tutorial Junwen ZhouClaire WilliamsBorislava Mihaylova Practical Application Open access 10 November 2023 Pages: 261 - 273
A Systematic Review of Methods Used by Pediatric Cost-Utility Analyses to Include Family Spillover Effects Ramesh LamsalE. Ann YehWendy J. Ungar Systematic Review Open access 09 November 2023 Pages: 199 - 217
Systematic Review of the Relative Social Value of Child and Adult Health Tessa PeasgoodMartin Howellthe Quality Of Life in Kids: Key evidence to strengthen decisions in Australia (QUOKKA), Tools for Outcomes Research to measure, value Child Health (TORCH) project teams Systematic Review Open access 09 November 2023 Pages: 177 - 198
Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate Cancer in the United States Christopher W. YeeMichael J. HarveyNoam Y. Kirson Original Research Article Open access 07 November 2023 Pages: 231 - 247
The Carer QALY Trap and Altruism in Economic Evaluations J. Mick TilfordAygul Tarlan Editorial 02 November 2023 Pages: 1553 - 1555
Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study Javier MarOliver IbarrondoMaíra Aguiar Original Research Article Open access 01 November 2023 Pages: 219 - 229
Transporting Comparative Effectiveness Evidence Between Countries: Considerations for Health Technology Assessments Alex J. TurnerCormac SammonJoshua Ray Practical Application Open access 27 October 2023 Pages: 165 - 176
Launch and Post-Launch Prices of Injectable Cancer Drugs in the US: Clinical Benefit, Innovation, Epidemiology, and Competition Daniel Tobias MichaeliThomas Michaeli Original Research Article Open access 19 October 2023 Pages: 117 - 131
Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective Diarmuid CoughlanOluwatomi ArisaStephen Rice Commentary 05 October 2023 Pages: 5 - 9
Economic Evaluations Comparing Deep Brain Stimulation to Best Medical Therapy for Movement Disorders: A Meta-Analysis Melissa LannonTaylor DudaSunjay Sharma Systematic Review 26 September 2023 Pages: 41 - 68
A Systematic Review of Methodologies Used in Models of the Treatment of Diabetes Mellitus Marina AntoniouCéu MateusAndrew Titman Systematic Review 22 September 2023 Pages: 19 - 40
Modelling Health State Utilities as a Transformation of Time to Death in Patients with Non-Small Cell Lung Cancer Anthony J. HatswellMohammad A. ChaudharyRachael Lawrance Original Research Article Open access 14 September 2023 Pages: 109 - 116
Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Thomas OttenRob RiemsmaSabine Grimm Correction Open access 04 September 2023 Pages: 1551 - 1551
Modelling Spillover Effects on Informal Carers: The Carer QALY Trap David J. MottHannah SchirrmacherChris Skedgel Current Opinion Open access 02 September 2023 Pages: 1557 - 1561
Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis Jedidiah I. MortonClara MarquinaZanfina Ademi Original Research Article Open access 22 August 2023 Pages: 91 - 107
The Difference Method Approach for Sampling Order Constrained Parameters: An Improved Implementation and Important Limitations Daniel Hill-McManus Practical Application 21 August 2023 Pages: 11 - 18
Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada Aneeka HafeezLauren E. CiprianoSisira Sarma Original Research Article 19 August 2023 Pages: 69 - 90
Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies Deborah A. MarshallBrittany GerberGillian R. Currie Scoping Review 18 August 2023 Pages: 1563 - 1588
Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review Marieke KrolNikkie HosseinniaLeona Hakkaart van Roijen Systematic Review Open access 17 August 2023 Pages: 1031 - 1050
Capturing Value Attributes in the Economic Evaluation of Ceftazidime with Avibactam for Treating Severe Aerobic Gram-Negative Bacterial Infections in the United Kingdom Jason GordonMaria GheorgheAmer Al-Taie Original Research Article Open access 16 August 2023 Pages: 1657 - 1673
Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland Michaela Carla BarbierAlicia FenglerOliver Gautschi Original Research Article Open access 12 August 2023 Pages: 1641 - 1655
Moving Forward with Taking a Societal Perspective: A Themed Issue on Productivity Costs, Consumption Costs and Informal Care Costs Werner BrouwerPieter van Baal Editorial 02 August 2023 Pages: 1027 - 1030
De Novo Cost-Effectiveness Model Framework for Nonalcoholic Steatohepatitis—Modeling Approach and Validation Peter GalGyorgyi FeldmajerInger Smith Original Research Article Open access 28 July 2023 Pages: 1629 - 1639
Estimating the Potential Benefits of Confirmatory Trials for Drugs with Accelerated Approval: A Comprehensive Value of Information Framework Boshen Jiao Original Research Article 25 July 2023 Pages: 1617 - 1627
Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations Kumar MukherjeeNecdet B. GunsoyGian Luca Di Tanna Systematic Review Open access 25 July 2023 Pages: 1589 - 1601
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens David TeigenRobert O. OpokaBjarne Robberstad Original Research Article Open access 18 July 2023 Pages: 1603 - 1615
Economic and Humanistic Burden of Osteoarthritis: An Updated Systematic Review of Large Sample Studies Xuejing JinWanxian LiangFeng Xie Systematic Review 18 July 2023 Pages: 1453 - 1467
An Alternative Measure of Health for Value Assessment: The Equal Value Life-Year Jonathan D. CampbellMelanie D. WhittingtonSteven D. Pearson Practical Application 17 July 2023 Pages: 1175 - 1182
Conducting Trial-Based Economic Evaluations Using R: A Tutorial Ângela Jornada BenJohanna M. van DongenJudith E. Bosmans Practical Application Open access 17 July 2023 Pages: 1403 - 1413
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How? Nancy J. DevlinTianxin PanRichard Norman Leading Article Open access 13 July 2023 Pages: 1165 - 1174